144 related articles for article (PubMed ID: 34599970)
1. Beta-adrenergic glaucoma drugs reduce lymphatic clearance from the eye: A sequential photoacoustic imaging study.
Hanna J; Yücel YH; Zhou X; Kim N; Irving H; Gupta N
Exp Eye Res; 2021 Nov; 212():108775. PubMed ID: 34599970
[TBL] [Abstract][Full Text] [Related]
2. Age-related decline of lymphatic drainage from the eye: A noninvasive in vivo photoacoustic tomography study.
Yücel YH; Cheng F; Cardinell K; Zhou X; Irving H; Gupta N
Exp Eye Res; 2020 May; 194():108029. PubMed ID: 32251650
[TBL] [Abstract][Full Text] [Related]
3. Active Lymphatic Drainage From the Eye Measured by Noninvasive Photoacoustic Imaging of Near-Infrared Nanoparticles.
Yücel YH; Cardinell K; Khattak S; Zhou X; Lapinski M; Cheng F; Gupta N
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2699-2707. PubMed ID: 29860456
[TBL] [Abstract][Full Text] [Related]
4. Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biol Pharm Bull; 2008 Aug; 31(8):1590-5. PubMed ID: 18670094
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
Chiang CH; Ho JI; Chen JL
J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
[TBL] [Abstract][Full Text] [Related]
6. The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.
Diestelhorst M; Roters S; Krieglstein GK
Graefes Arch Clin Exp Ophthalmol; 1997 Jan; 235(1):20-6. PubMed ID: 9034838
[TBL] [Abstract][Full Text] [Related]
7. Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits.
Fayyaz A; Ranta VP; Toropainen E; Vellonen KS; Ricci GD; Reinisalo M; Heikkinen EM; Gardner I; Urtti A; Jamei M; Del Amo EM
Mol Pharm; 2020 Feb; 17(2):588-594. PubMed ID: 31794668
[TBL] [Abstract][Full Text] [Related]
8. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
Olateju SO; Ajayi AA
Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
[TBL] [Abstract][Full Text] [Related]
9. Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.
Sato T; Muto T; Ishibashi Y; Roy S
Curr Eye Res; 2001 Oct; 23(4):298-306. PubMed ID: 11852432
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
Phan TM; Nguyen KP; Giacomini JC; Lee DA
J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
[TBL] [Abstract][Full Text] [Related]
11. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
Brooks AM; Gillies WE
Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
[TBL] [Abstract][Full Text] [Related]
13. In vivo cAMP level in rabbit iris-ciliary body after topical epinephrine treatment.
Liu JH; Gallar J
Curr Eye Res; 1996 Oct; 15(10):1025-32. PubMed ID: 8921241
[TBL] [Abstract][Full Text] [Related]
14. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
Schuman JS
Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
[TBL] [Abstract][Full Text] [Related]
15. Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy.
Sponsel WE; Terry S; Khuu HD; Lam KW; Frenzel H
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S210-3. PubMed ID: 10416765
[TBL] [Abstract][Full Text] [Related]
16. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
Larsson LI
Arch Ophthalmol; 2001 Apr; 119(4):492-5. PubMed ID: 11296014
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility.
Kiland JA; Gabelt BT; Kaufman PL
Exp Eye Res; 2004 Mar; 78(3):639-51. PubMed ID: 15106944
[TBL] [Abstract][Full Text] [Related]
18. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Frishman WH; Fuksbrumer MS; Tannenbaum M
J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
[TBL] [Abstract][Full Text] [Related]
19. Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency.
Loma P; Guzman-Aranguez A; Perez de Lara MJ; Pintor J
Exp Eye Res; 2015 May; 134():141-7. PubMed ID: 25701803
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure reduction with topically administered pilocarpine, timolol and betaxolol in normal tension glaucoma.
Nyman K
Acta Ophthalmol (Copenh); 1993 Oct; 71(5):686-90. PubMed ID: 8109215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
